Reader View AI Reader View Novo Nordisk Q3 2026 slides: sales recover, outlook raised on GLP-1 growth www.investing.com · November 4, 2026 · 13:30 Paywall detected This article has a paywall The publisher blocks direct access to this article. Generate with AI Open link